Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

Cited In for PubMed (Select 20885893)


Detection of pulmonary metastases with the novel radiolabeled molecular probe, (99m)Tc-RRL.

Yao N, Yan P, Wang RF, Zhang CL, Ma C, Chen XQ, Zhao Q, Hao P.

Int J Clin Exp Med. 2015 Feb 15;8(2):1726-36. eCollection 2015.


Preclinical characterization and validation of a dual-labeled trastuzumab-based imaging agent for diagnosing breast cancer.

Wang X, Aldrich MB, Marshall MV, Sevick-Muraca EM.

Chin J Cancer Res. 2015 Feb;27(1):74-82. doi: 10.3978/j.issn.1000-9604.2015.01.02.


Current status of optical imaging for evaluating lymph nodes and lymphatic system.

Lee ES, Kim TS, Kim SK.

Korean J Radiol. 2015 Jan-Feb;16(1):21-31. doi: 10.3348/kjr.2015.16.1.21. Epub 2015 Jan 9. Review.


Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging.

Zeglis BM, Davis CB, Abdel-Atti D, Carlin SD, Chen A, Aggeler R, Agnew BJ, Lewis JS.

Bioconjug Chem. 2014 Dec 17;25(12):2123-8. doi: 10.1021/bc500499h. Epub 2014 Nov 26.


Fluorescent imaging of cancerous tissues for targeted surgery.

Bu L, Shen B, Cheng Z.

Adv Drug Deliv Rev. 2014 Sep 30;76:21-38. doi: 10.1016/j.addr.2014.07.008. Epub 2014 Jul 24. Review.


Bimodal imaging probes for combined PET and OI: recent developments and future directions for hybrid agent development.

Seibold U, Wängler B, Schirrmacher R, Wängler C.

Biomed Res Int. 2014;2014:153741. doi: 10.1155/2014/153741. Epub 2014 Apr 16. Review.


Stable confinement of positron emission tomography and magnetic resonance agents within carbon nanotubes for bimodal imaging.

Cisneros BT, Law JJ, Matson ML, Azhdarinia A, Sevick-Muraca EM, Wilson LJ.

Nanomedicine (Lond). 2014 Nov;9(16):2499-509. doi: 10.2217/nnm.14.26.


Targeting pili in enterococcal pathogenesis.

Pinkston KL, Singh KV, Gao P, Wilganowski N, Robinson H, Ghosh S, Azhdarinia A, Sevick-Muraca EM, Murray BE, Harvey BR.

Infect Immun. 2014 Apr;82(4):1540-7. doi: 10.1128/IAI.01403-13. Epub 2014 Jan 22.


Advancing the translation of optical imaging agents for clinical imaging.

Sevick-Muraca EM, Akers WJ, Joshi BP, Luker GD, Cutler CS, Marnett LJ, Contag CH, Wang TD, Azhdarinia A.

Biomed Opt Express. 2013 Jan 1;4(1):160-70. doi: 10.1364/BOE.4.000160. Epub 2012 Dec 18.


Aptamer-functionalized, ultra-small, monodisperse silica nanoconjugates for targeted dual-modal imaging of lymph nodes with metastatic tumors.

Tang L, Yang X, Dobrucki LW, Chaudhury I, Yin Q, Yao C, Lezmi S, Helferich WG, Fan TM, Cheng J.

Angew Chem Int Ed Engl. 2012 Dec 14;51(51):12721-6. doi: 10.1002/anie.201205271. Epub 2012 Nov 7. No abstract available.


Development of copper based drugs, radiopharmaceuticals and medical materials.

Szymański P, Frączek T, Markowicz M, Mikiciuk-Olasik E.

Biometals. 2012 Dec;25(6):1089-112. doi: 10.1007/s10534-012-9578-y. Epub 2012 Aug 23. Review.


Multimodality imaging of breast cancer experimental lung metastasis with bioluminescence and a monoclonal antibody dual-labeled with 89Zr and IRDye 800CW.

Hong H, Zhang Y, Severin GW, Yang Y, Engle JW, Niu G, Nickles RJ, Chen X, Leigh BR, Barnhart TE, Cai W.

Mol Pharm. 2012 Aug 6;9(8):2339-49. doi: 10.1021/mp300277f. Epub 2012 Jul 19.


Seeing it through: translational validation of new medical imaging modalities.

Aldrich MB, Marshall MV, Sevick-Muraca EM, Lanza G, Kotyk J, Culver J, Wang LV, Uddin J, Crews BC, Marnett LJ, Liao JC, Contag C, Crawford JM, Wang K, Reisdorph B, Appelman H, Turgeon DK, Meyer C, Wang T.

Biomed Opt Express. 2012 Apr 1;3(4):764-76. doi: 10.1364/BOE.3.000764. Epub 2012 Mar 22.


Biophotonics techniques for structural and functional imaging, in vivo.

Ardeshirpour Y, Gandjbakhche AH, Najafizadeh L.

Anal Cell Pathol (Amst). 2012;35(5-6):317-37. doi: 10.3233/ACP-2012-0058. Review.


Advances in molecular imaging: targeted optical contrast agents for cancer diagnostics.

Hellebust A, Richards-Kortum R.

Nanomedicine (Lond). 2012 Mar;7(3):429-45. doi: 10.2217/nnm.12.12. Review.


Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets.

Cohen R, Stammes MA, de Roos IH, Stigter-van Walsum M, Visser GW, van Dongen GA.

EJNMMI Res. 2011 Dec 1;1(1):31. doi: 10.1186/2191-219X-1-31.


In vivo bio-imaging using chlorotoxin-based conjugates.

Stroud MR, Hansen SJ, Olson JM.

Curr Pharm Des. 2011 Dec;17(38):4362-71. Review.


Dual-labeling strategies for nuclear and fluorescence molecular imaging: a review and analysis.

Azhdarinia A, Ghosh P, Ghosh S, Wilganowski N, Sevick-Muraca EM.

Mol Imaging Biol. 2012 Jun;14(3):261-76. doi: 10.1007/s11307-011-0528-9. Review.


Using in-vivo fluorescence imaging in personalized cancer diagnostics and therapy, an image and treat paradigm.

Ardeshirpour Y, Chernomordik V, Capala J, Hassan M, Zielinsky R, Griffiths G, Achilefu S, Smith P, Gandjbakhche A.

Technol Cancer Res Treat. 2011 Dec;10(6):549-60. Review.


Characterization of chemical, radiochemical and optical properties of a dual-labeled MMP-9 targeting peptide.

Azhdarinia A, Wilganowski N, Robinson H, Ghosh P, Kwon S, Lazard ZW, Davis AR, Olmsted-Davis E, Sevick-Muraca EM.

Bioorg Med Chem. 2011 Jun 15;19(12):3769-76. doi: 10.1016/j.bmc.2011.04.054. Epub 2011 May 6.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk